Michelson, David

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease

Egan, M. F., Mukai, Y., Voss, T., Kost, J., Stone, J., Furtek, C., Mahoney, E., Cummings, J. L., Tariot, P. N., Aisen, P. S., et al. (2019) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 81

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: Randomised, placebo-controlled trial

Michelson, D., Allgulander, C., Dantendorfer, K., Knezevic, A., Maierhofer, D., Micev, V., Paunovic, V. R., Timotijevic, I., Sarkar, N., Skoglund, L., et al. (2001) · British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 62

Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder

Spencer, T. J., Newcorn, J. H., Kratochvil, C. J., Ruff, D., Michelson, D., & Biederman, J. (2005) · Pediatrics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 62

Brain Kinetics of Paroxetine and Fluoxetine on the Third Day of Placebo Substitution: A Fluorine MRS Study

Henry, M. E., Moore, C. M., Kaufman, M. J., Michelson, D., Schmidt, M. E., Stoddard, E., Vuckevic, A. J., Berreira, P. J., Cohen, B. M., & Renshaw, P. F. (2000) · American Journal of Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 61

Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications

Herring, W. J., Roth, T., Krystal, A. D., & Michelson, D. (2019) · Journal of Sleep Research

Sleep and related disordersSleep and Wakefulness Research

Cited by 53

Training raters to assess adult ADHD: reliability of ratings

Adler, L. A., Spencer, T., Faraone, S. V., Reimherr, F. W., Kelsey, D., Michelson, D., & Biederman, J. (2005) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderReliability and Agreement in Measurement

Cited by 51

Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder

Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 39

A comparison of North American versus non-North American ADHD study populations

Buitelaar, J. K., Barton, J., Danckaerts, M., Friedrichs, E., Gillberg, C., Hazell, P. L., Hellemans, H., Johnson, M., Kalverdijk, L. J., Masi, G., et al. (2006) · European Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 38